Related Experiment Videos
Drug-induced hepatic injury
1Storr Liver Unit, University of Sydney at Westmead Hospital, NSW, Australia. geoffF@westmed.wh.usyd.edu.au
Journal of Gastroenterology and Hepatology
|January 4, 1998
Summary
Drug-induced liver injury presents a diagnostic challenge, mimicking various liver diseases. Diagnosis relies on circumstantial evidence, temporal relationships, and exclusion of other causes, with rechallenge being definitive.
Area of Science:
- Hepatology
- Toxicology
- Internal Medicine
Background:
- Drug-induced liver injury (DILI) is a significant cause of severe hepatic damage.
- DILI can manifest with diverse hepatic lesions, complicating diagnosis for clinicians and pathologists.
- Diagnosis is often circumstantial, requiring careful evaluation of drug exposure and clinical presentation.
Purpose of the Study:
- To review contemporary understanding of drug-induced hepatic injury.
- To explore factors predisposing to dose-dependent liver injury.
- To discuss specific drug examples and the hepatotoxicity of Chinese herbal medicines.
Main Methods:
- Review of contemporary literature on drug-induced hepatic injury.
- Discussion of diagnostic challenges and supporting evidence.
- Case examples of specific drugs and their hepatic effects.
Main Results:
- Drug reactions can mimic all known hepatobiliary diseases.
- Acetaminophen and methotrexate exemplify dose-dependent and fibrotic liver injury, respectively.
- Flucloxacillin can cause cholestatic hepatitis and vanishing bile duct syndrome; minocycline and diclofenac rarely cause DILI.
Conclusions:
- Diagnosis of DILI requires a comprehensive approach, including temporal association, exclusion of other diseases, and biopsy findings.
- Understanding specific drug toxicities is crucial for accurate diagnosis and management.
- The potential hepatotoxicity of Chinese herbal medicines warrants further investigation.